Amalgamated Bank Myriad Genetics Inc Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Myriad Genetics Inc stock. As of the latest transaction made, Amalgamated Bank holds 26,656 shares of MYGN stock, worth $359,856. This represents 0.01% of its overall portfolio holdings.

Number of Shares

26,656

Previous 27,421 2.79%

Holding current value

$359,856

Previous $671,000 8.79%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$23.97 - $28.6 $18,337 - $21,879	-765 Reduced 2.79%	26,656 $730,000
Q2 2024 Aug 12, 2024	SELL	$17.98 - $25.47 $14,761 - $20,910	-821 Reduced 2.91%	27,421 $671,000
Q1 2024 Apr 23, 2024	SELL	$17.59 - $23.59 $72,418 - $97,120	-4,117 Reduced 12.72%	28,242 $602,000
Q4 2023 Feb 06, 2024	BUY	$13.91 - $21.32 $9,625 - $14,753	692 Added 2.19%	32,359 $619,000
Q3 2023 Nov 08, 2023	SELL	$15.99 - $23.22 $15,398 - $22,360	-963 Reduced 2.95%	31,667 $508,000
Q2 2023 Aug 11, 2023	SELL	$17.56 - $23.76 $22,371 - $30,270	-1,274 Reduced 3.76%	32,630 $756,000
Q1 2023 May 02, 2023	SELL	$15.26 - $23.75 $41,400 - $64,433	-2,713 Reduced 7.41%	33,904 $788,000
Q4 2022 Feb 10, 2023	BUY	$14.51 - $20.99 $4,106 - $5,940	283 Added 0.78%	36,617 $531,000
Q3 2022 Nov 09, 2022	BUY	$18.21 - $27.88 $6,227 - $9,534	342 Added 0.95%	36,334 $693,000
Q2 2022 Aug 15, 2022	BUY	$16.45 - $25.88 $4,063 - $6,392	247 Added 0.69%	35,992 $654,000
Q1 2022 Jun 30, 2022	SELL	$22.67 - $28.01 $38,652 - $47,757	-1,705 Reduced 4.55%	35,745 $901,000
Q4 2021 Feb 15, 2022	BUY	$24.13 - $32.63 $5,163 - $6,982	214 Added 0.57%	37,450 $1.03 Million
Q3 2021 Oct 29, 2021	SELL	$29.97 - $36.66 $18,371 - $22,472	-613 Reduced 1.62%	37,236 $1.2 Million
Q2 2021 Aug 16, 2021	BUY	$25.39 - $32.61 $960,986 - $1.23 Million	37,849 New	37,849 $1.16 Million
Q2 2020 Aug 10, 2020	SELL	$10.69 - $16.49 $125,885 - $194,186	-11,776 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$9.78 - $29.53 $2,484 - $7,500	-254 Reduced 2.11%	11,776 $169,000
Q4 2019 Feb 13, 2020	BUY	$20.93 - $35.1 $19,130 - $32,081	914 Added 8.22%	12,030 $328,000
Q3 2019 Nov 13, 2019	SELL	$22.08 - $47.08 $5,453 - $11,628	-247 Reduced 2.17%	11,116 $318,000
Q2 2019 Aug 14, 2019	BUY	$22.67 - $35.0 $13,987 - $21,595	617 Added 5.74%	11,363 $316,000
Q1 2019 May 15, 2019	BUY	$26.93 - $34.7 $9,210 - $11,867	342 Added 3.29%	10,746 $357,000
Q4 2018 Feb 15, 2019	BUY	$27.23 - $45.56 $142,331 - $238,142	5,227 Added 100.97%	10,404 $302,000
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $204,155 - $273,547	-5,434 Reduced 51.21%	5,177 $238,000
Q2 2018 Jul 18, 2018	BUY	$27.75 - $40.17 $36,130 - $52,301	1,302 Added 13.99%	10,611 $397,000
Q1 2018 May 22, 2018	SELL	$28.83 - $41.01 $4,180 - $5,946	-145 Reduced 1.53%	9,309 $275,000
Q4 2017 Feb 13, 2018	BUY	$28.45 - $37.14 $21,934 - $28,634	771 Added 8.88%	9,454 $325,000
Q3 2017 Nov 09, 2017	BUY	$24.01 - $36.2 $208,478 - $314,324	8,683	8,683 $314,000

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.09B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Myriad Genetics Inc Transaction History